Testing effectiveness (Phase 2)Study completedNCT03218995
What this trial is testing
Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 15